World Trade Center Health Program Scientific/Technical Advisory Committee (WTCHP STAC), 50128-50129 [2021-19224]

Agencies

• Centers for Disease Control and Prevention
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 86, Number 170 (Tuesday, September 7, 2021)]
[Notices]
[Pages 50128-50129]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19224]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2021-0094; NIOSH 248-H]


World Trade Center Health Program Scientific/Technical Advisory 
Committee (WTCHP STAC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following virtual meeting for the World Trade Center 
Health Program Scientific/Technical Advisory Committee (WTCHP STAC). A 
notice of this WTCHP STAC meeting has also been posted on the committee 
website at: https://www.cdc.gov/wtc/stac_meeting.html.

DATES: The meeting will be held on September 28, 2021 from 11:00 a.m. 
to 4:00 p.m., EDT, and on September 29, 2021 from 11:00 a.m. to 4:00 
p.m., EDT.
    Written comments received by September 21, 2021 will be provided to 
the STAC prior to the meeting.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0094; NIOSH 248-H by mail. CDC does not accept comments by email.
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: Docket number CDC-2021-0094; NIOSH 248-H, c/o Sherri 
Diana, NIOSH Docket Office, National Institute for Occupational Safety 
and Health, 1090 Tusculum Avenue, MS C-34, Cincinnati, Ohio 45226.
    Instructions: All submissions received must include the Agency name 
and Docket Number. Written public comments received by September 21, 
2021, will be provided to the WTCHP STAC prior to the meeting. Docket 
number CDC-2021-0094; NIOSH 248-H will close September 29, 2021.

FOR FURTHER INFORMATION CONTACT: Tania Carre[oacute]n-Valencia, Ph.D., 
Designated Federal Officer, World Trade Center Health Program, National 
Institute for Occupational Safety and Health, CDC, 1600 Clifton Road, 
NE, MS R-12, Atlanta, GA 30329-4027, Telephone: (513) 841-4515; Email: 
[email protected].

SUPPLEMENTARY INFORMATION:
    Background: The WTCHP STAC was established by Title I of the James 
Zadroga 9/11 Health and Compensation Act of 2010, Public Law 111-347 
(January 2, 2011), amended by Public Law 114-113 (Dec. 18, 2015) and 
Public Law 116-59 (Sept. 27, 2019), adding Title XXXIII to the Public 
Health Service (PHS) Act (codified at 42 U.S.C. 300mm to 300mm-61).
    Purpose: The purpose of the WTCHP STAC is to review scientific and 
medical evidence and to make recommendations to the Administrator of 
the World Trade Center (WTC) Health Program regarding additional WTC 
Health Program eligibility criteria, potential additions to the List of 
WTC-Related Health Conditions, and research regarding certain health 
conditions related to the September 11, 2001, terrorist attacks.
    Title XXXIII of the PHS Act established the WTC Health Program 
within the Department of Health and Human Services (HHS). The WTC 
Health Program provides medical monitoring and treatment benefits to 
eligible firefighters and related personnel, law enforcement officers, 
and rescue, recovery, and cleanup workers who responded to the 
September 11, 2001, terrorist attacks in New York City, at the 
Pentagon, and in Shanksville, Pennsylvania (responders), and to 
eligible persons who were present in the dust or dust cloud on 
September 11, 2001 or who worked, resided, or attended school, 
childcare, or adult daycare in the New York City disaster area 
(survivors). Certain specific activities of the Administrator of the 
WTC Health Program are reserved to the Secretary, HHS, to delegate at 
his discretion; other duties not explicitly reserved to the Secretary, 
HHS, are assigned to the Director of the National Institute for 
Occupational Safety and Health (NIOSH). The administration of the WTCHP 
STAC is left to the Director of NIOSH in his role as Administrator. CDC 
and NIOSH provide funding, staffing, and administrative support 
services for the WTCHP STAC. The charter was reissued on May 12, 2021 
and will expire on May 12, 2023.
    Matters to be Considered: The agenda will include an overview of 
the Program's research activities in the past 10 years and discussion 
of the Administrator's request that the STAC provide a recommendation 
regarding whether to add uterine cancer to the List of health 
conditions eligible for coverage by the WTC Health Program. A white 
paper on scientific considerations developed to assist the Committee in 
their deliberations is available on the WTC Health Program website at 
https://www.cdc.gov/wtc/stac_meeting.html. An agenda is also posted on 
the WTC Health Program website at https://www.cdc.gov/wtc/stac_meeting.html.
    Agenda items are subject to change as priorities dictate. Meeting 
Information: This is a virtual meeting conducted via Zoom. The public 
is welcome to follow the proceedings via live webcast on the World Wide 
Web. No registration is required. The webcast link for September 28-29, 
2021 is https://www.ustream.tv/channel/QyXBRzYjVCS. For additional 
information please visit the WTC Health Program website at https://www.cdc.gov/wtc/stac_meeting.html.

Public Participation

    Interested parties may participate in this activity by submitting 
written views, opinions, recommendations, and

[[Page 50129]]

data. You may submit comments on any topic related to this activity. 
Comments received, including attachments and other supporting 
materials, are part of the public record and subject to public 
disclosure. Do not include any information in your comment or 
supporting materials that you consider confidential or inappropriate 
for public disclosure. If you include your name, contact information, 
or other information that identifies you in the body of your comments, 
that information will be on public display. CDC will review all 
submissions and may choose to redact, or withhold, submissions 
containing private or proprietary information such as Social Security 
numbers, medical information, inappropriate language, or duplicate/near 
duplicate examples of a mass-mail campaign. CDC will carefully consider 
all comments submitted into the docket. CDC does not accept comment by 
email.
    Oral Public Comment: The public is welcome to participate, via 
Zoom, during the public comment periods on September 28, 2021, from 
11:30 a.m. to 12:00 p.m., EDT, and on September 29, 2021, from 12:10 
p.m. to 12:40 p.m., EDT. Please note that the public comment periods 
end at the times indicated above. Each commenter will be provided up to 
five minutes for comment. A limited number of time slots are available 
and will be assigned on a first come-first served basis. Members of the 
public who wish to address the WTCHP STAC during the oral public 
comment sessions must sign up by providing their name and desired date 
for commenting to Mia Wallace, Committee Management Specialist, via 
email: [email protected], or the addresses section provided in this 
notice by September 21, 2021.
    Written Public Comment: Written comments will also be accepted from 
those unable to attend the public session per the instructions provided 
in the addresses section above. Written comments received in advance of 
the meeting will be included in the official record of the meeting. 
Written comments received by September 21, 2021 will be provided to the 
STAC prior to the meeting. The docket will close on September 29, 2021.
    Policy on Redaction of Committee Meeting Transcripts (Public 
Comment): Transcripts will be prepared and posted to https://www.regulations.gov within 60 days after the meeting. If a person 
making a comment gives their name, no attempt will be made to redact 
that name. NIOSH will take reasonable steps to ensure that individuals 
making public comments are aware that their comments (including their 
name, if provided) will appear in a transcript of the meeting posted on 
a public website. Such reasonable steps include a statement read at the 
start of the meeting stating that transcripts will be posted, and names 
of speakers will not be redacted. If individuals in making a statement 
reveal personal information (e.g., medical information) about 
themselves, that information will not usually be redacted. The CDC 
Freedom of Information Act coordinator will, however, review such 
revelations in accordance with the Freedom of Information Act and, if 
deemed appropriate, will redact such information. Disclosures of 
information concerning third party medical information will be 
redacted.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-19224 Filed 9-3-21; 8:45 am]
BILLING CODE 4163-18-P